We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-1.77%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$180M
AUM Growth
+$3.95M
Cap. Flow
+$10.6M
Cap. Flow %
5.89%
Top 10 Hldgs %
37.35%
Holding
45
New
7
Increased
15
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
WAT icon
Waters Corp
WAT
+$4.79M
2
RVTY icon
Revvity
RVTY
+$3.52M
3
BAX icon
Baxter International
BAX
+$3.31M
4
HCA icon
HCA Healthcare
HCA
+$2.99M
5
THC icon
Tenet Healthcare
THC
+$2.97M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.75M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.26M
3
CRL icon
Charles River Laboratories
CRL
+$3.21M
4
LHCG
LHC Group LLC
LHCG
+$3.12M
5
HUM icon
Humana
HUM
+$2.43M

Sector Composition

Rank Sector Weight
1 Healthcare 99.5%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$89.5B
$7.81M 4.34%
42,500
+15,000
+55% +$2.99M
TMO icon
2
Thermo Fisher Scientific
TMO
$220B
$7.61M 4.23%
15,000
+2,500
+20% +$1.4M
BSX icon
3
Boston Scientific
BSX
$71.5B
$7.17M 3.98%
185,000
– –
CI icon
4
Cigna
CI
$74.6B
$6.94M 3.86%
25,000
– –
BAX icon
5
Baxter International
BAX
$14.2B
$6.46M 3.59%
120,000
+55,000
+85% +$3.31M
DHR icon
6
Danaher
DHR
$144B
$6.46M 3.59%
28,200
-1,128
-4% -$276K
ZBH icon
7
Zimmer Biomet
ZBH
$18.4B
$6.27M 3.49%
60,000
+10,000
+20% +$1.1M
THC icon
8
Tenet Healthcare
THC
$21.1B
$6.19M 3.44%
120,000
+50,000
+71% +$2.97M
SYK icon
9
Stryker
SYK
$130B
$6.18M 3.43%
30,500
– –
JNJ icon
10
Johnson & Johnson
JNJ
$625B
$6.13M 3.4%
37,500
+12,500
+50% +$2.12M
A icon
11
Agilent Technologies
A
$41.2B
$6.08M 3.38%
50,000
+20,000
+67% +$2.57M
UNH icon
12
UnitedHealth
UNH
$370B
$6.06M 3.37%
12,000
-3,500
-23% -$1.84M
MCK icon
13
McKesson
MCK
$101B
$5.95M 3.31%
17,500
-5,000
-22% -$1.74M
UHS icon
14
Universal Health Services
UHS
$10.5B
$5.73M 3.19%
65,000
+17,500
+37% +$1.81M
LLY icon
15
Eli Lilly
LLY
$1.06T
$5.66M 3.15%
17,500
-4,002
-19% -$1.27M
ISRG icon
16
Intuitive Surgical
ISRG
$134B
$5.62M 3.13%
30,000
+10,000
+50% +$2.15M
ACHC icon
17
Acadia Healthcare
ACHC
$2.94B
$5.47M 3.04%
70,000
– –
CAH icon
18
Cardinal Health
CAH
$55.4B
$5.33M 2.96%
80,000
+40,000
+100% +$2.54M
HUM icon
19
Humana
HUM
$46.2B
$5.09M 2.83%
10,500
-5,000
-32% -$2.43M
ELV icon
20
Elevance Health
ELV
$85.5B
$5M 2.78%
11,000
-4,000
-27% -$1.91M
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$12.4B
$4.66M 2.59%
55,000
+7,500
+16% +$668K
COR icon
22
Cencora
COR
$61.2B
$4.06M 2.26%
30,000
-10,000
-25% -$1.44M
WAT icon
23
Waters Corp
WAT
$39.9B
$4.04M 2.25%
+15,000
New +$4.79M
NVO
24
Novo Nordisk
NVO
$209B
$3.98M 2.21%
80,000
-40,000
-33% -$2.14M
CNC icon
25
Centene
CNC
$32.5B
$3.89M 2.16%
50,000
-25,000
-33% -$2.23M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q3 2022 Portfolio in Review

As of Q3 2022, Sivik Global Healthcare held 45 positions worth $180M, up 2.2% from $176M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sivik Global Healthcare deployed $10.6M of net new capital in Q3 2022, opening 7 new positions and adding to 15 existing holdings. Its largest new stake was Waters Corp: 15,000 shares worth $4.04M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 96% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $3.26M trimmed.

  • Sivik Global Healthcare's largest Q3 2022 buy was Waters Corp: 15,000 shares worth $4.04M.
  • Sivik Global Healthcare added most to Baxter International in Q3 2022, an estimated $3.31M increase.
  • Sivik Global Healthcare's biggest Q3 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $3.26M.
  • Sivik Global Healthcare fully exited Sanofi in Q3 2022, selling an estimated $3.75M.
  • Sivik Global Healthcare's ten largest holdings make up 37% of its $180M portfolio in Q3 2022.
  • Sivik Global Healthcare opened 7 new positions and closed 4 in Q3 2022.
  • Sivik Global Healthcare's portfolio value rose 2.2% quarter-over-quarter to $180M.

Based on Sivik Global Healthcare's 13F filing for Q3 2022, filed 4 Nov 2022.